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In 1997, Taiwan made highly active antiretroviral ther-
apy (HAART) available without cost to HIV-infected per-
sons; in 2001, a national web-based surveillance system 
was implemented. Healthcare workers use the system to 
monitor patients’ conditions and can intervene when neces-
sary. Free HAART, coupled with the surveillance system, 
appears to have increased survival rates of HIV-infected 
persons with tuberculosis in Taiwan.
M
ost experts believe that complete and efﬁ  cient sur-
veillance is the top priority in detecting and prevent-
ing outbreaks of emerging infectious diseases, such as 
tuberculosis (TB) and HIV coinfection (1–3) or inﬂ  uenza 
virus A (H5N1). In Taiwan, a national web-based surveil-
lance system established in July 2001 provides complete 
and efﬁ  cient reporting and management of persons coin-
fected with HIV and TB and enables healthcare workers 
to identify noncompliance with therapy and to intervene 
when necessary. After highly active antiretroviral therapy 
(HAART) became available free of charge in Taiwan in 
April 1997, the death rate for HIV-infected persons de-
creased from 5.7% in 1997 to 1.8% in 2006. To determine 
whether implementation of the national surveillance sys-
tem in combination with the availability of free HAART 
further increased survival rates of HIV-infected persons 
with TB, we compared their demographic, clinical, and 
behavioral characteristics during 3 periods: 1) before free 
HAART was available (1993–1996); 2) after free HAART 
was available but before the surveillance system was im-
plemented (1998–2000); and 3) after both free HAART 
and the surveillance system were available (2002–2006).
The Study
We obtained data on persons with HIV/AIDS and TB 
from the national databank at the Centers for Disease Con-
trol (CDC Taiwan) of the Department of Health, Taiwan. 
Coinfection with HIV and TB was deﬁ  ned as HIV infec-
tion in persons in whom TB was later diagnosed. A total of 
660 persons with both HIV and TB were reported during 
1993–2006.
We used Microsoft Excel XP spreadsheet (Microsoft, 
Redmond, WA, USA) and SAS version 9.1 (SAS Insti-
tute Inc., Cary, NC, USA) for statistical analysis. The χ2 
goodness-of-ﬁ  t test with type I error = 0.05 was used to 
examine differences in demographic, clinical, and behav-
ioral characteristics of persons with HIV and TB coinfec-
tion during 1993–2006. Multivariates for analysis were 
sex and age, results of sputum smear and sputum culture, 
pulmonary radiographic diagnosis, TB types (extrapulmo-
nary and nonextrapulmonary), mode of HIV transmission, 
sexual behavior, compliance with HAART, and use of the 
surveillance system (Table 1). We used the Kaplan-Meier 
method (4) from SAS to evaluate and compare the effect on 
survival rates of different factors in persons coinfected with 
HIV and TB 1 year after reported TB diagnosis.
Kaplan-Meier analysis yielded the following results: 
63% of persons coinfected with HIV and TB survived dur-
ing 1993–1996; 78% survived during 1998–2000; and 93% 
survived during 2002–2006 (p<0.0001) (Figure). We then 
applied Cox proportional hazards modeling (5) to each 
variable to assess the effect on survival after implemen-
tation of HAART and the surveillance system. Age <45 
years, negative sputum smear, availability of free HAART, 
and implementation of the national surveillance system 
substantially increased survival rates of persons coinfected 
with HIV and TB (Table 2).
Conclusion
Many factors can increase survival rates of HIV-in-
fected persons, such as HAART (6–9), prevention of op-
portunistic infections, patient attitude, healthcare worker 
knowledge, and promotion of health education. Our data 
indicate that national web-based surveillance reporting and 
management, coupled with the availability of free HAART, 
increase survival rates of persons coinfected with HIV and 
TB (p<0.0001).
Taiwan’s national web-based surveillance system en-
ables healthcare workers to follow, record, and understand 
the conditions of patients without geographic limitations. 
Physicians, public health nurses, health administrators, and 
other healthcare professionals in local through federal gov-
ernment agencies can use the system to follow up and man-
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age the condition of persons coinfected with HIV and TB. 
For example, public health nurses from national healthcare 
centers visit such patients regularly, record treatments, and 
assess their conditions and compliance with therapy; staff 
from central health department monitor and supervise the 
condition of each patient through the system. In this way, 
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Table 1. Demographic and clinical characteristics of 660 persons coinfected with HIV and TB, Taiwan, 1993–2006* 
Characteristics  No. (%) persons  p value† 
Sex   <0.0001 
 M  612 (92.7)   
 F  48 (7.3)   
Age, y   <0.0001 
 <45  498 (75.5)   
 >45  162 (24.5)   
Sputum smear (n = 484)   <0.0001 
 Negative   287 (59.3)   
 Positive  197 (40.7)   
Sputum culture (n = 340)   0.0172 
 Negative   148 (43.5)   
 Positive  192 (56.5)   
Pulmonary radiograph results (n = 531)    <0.0001 
 Normal  54 (10.2)   
 Abnormal  477 (89.8)   
Extrapulmonary TB‡   <0.0001 
 Yes  73 (11.1)   
 No  587 (88.9)   
Risk behavior (n = 554)   <0.0001 
 Sexual  513 (92.6)   
  Injection drug user  41 (7.4)   
Sexual behavior (n = 566)   0.0004 
 Heterosexual  325 (57.4)   
  Homosexual or bisexual  241 (42.6)   
Highly active antiretroviral therapy‡ (n = 534)    <0.0001 
 1998–2006  (free)  493 (92.3)   
 1993–1996  (not  free)  41 (7.7)   
National web-based surveillance reporting and management system (n = 520)    <0.0001 
 2002–2006  (available)  386  (74.2)   
  1998–2000 (not available)  134 (25.8)   
Outcome§ (n = 606)   <0.0001 
 Survival  522 (86.1)   
 Death  84 (13.9)   
*TB, tuberculosis. 
†Ȥ
2 goodness-of-fit test with type I error = 0.05 used to examine differences in demographic, clinical, and behavioral characteristics. 
‡Definition following World Health Organization guideline (1). 
§Tracking for 1 year from report of TB diagnosis. 
Figure. Kaplan-Meier analysis of survival of HIV-infected 
patients with tuberculosis in Taiwan during 3 different periods: 
before free highly active antiretroviral therapy (HAART) was 
available (1993–1996, black line); B) after free HAART was 
available but before the national web-based reporting and 
management surveillance system was implemented (1998–
2000, red line); and C) after free HAART and the surveillance 
system were available (2002–2006, blue line).the system may increase patients’ compliance and thus 
their survival rates (10–14).
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Table 2. Cox regression model of possible risk factors for death among persons coinfected with HIV and tuberculosis, Taiwan, 1993–
2006
Risk factor  Hazard ratio  95% Confidence interval  p value 
Sex (F)  1.462 0.292–7.303 0.6438
Age (>45 y)  2.907 1.162–7.272 0.0226
Sputum smear positive  2.722 1.008–7.349 0.0482
Pulmonary radiograph abnormal  7.006 0.848–57.916  0.0708
Pulmonary tuberculosis  3.169 0.641–15.674  0.1573
Heterosexual 2.049 0.794–5.290 0.1333
Before availability of free highly active antiretroviral therapy*  8.398 2.170–32.508  0.0021
Before implementation of national web-based surveillance reporting and 
management system† 
7.664 2.115–27.768 0.0019
*1993–1996. 
†1998–2000. 
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